Interleukin-4 (IL-4) as a Marker of Atherosclerosis

This study has been withdrawn prior to enrollment.
Sponsor:
Collaborator:
The Intensive Care Unit Departmental Funding
Information provided by:
Melbourne Health
ClinicalTrials.gov Identifier:
NCT00256035
First received: November 17, 2005
Last updated: April 23, 2015
Last verified: April 2015
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given